A pill to treat obesity developed by Israeli and U.S. firms is in the pipeline for a major deal with a big pharma company to market the product, Globes reported on Wednesday.
Sources said that startup Gelesis Inc. has a pill that expands in the stomach to give the sensation of being full, thereby reducing food intake and resulting in weight loss.
Gelesis was founded in 2006 by CEO Yishai Zohar at Boston-based incubator PureTech Ventures. Although headquartered in Boston, Gelesis has an Israeli development center.
Gelesis reportedly plans to submit the product for approval to the U.S. Food and Drug Administration (FDA) as a medication. The product must complete clinical trials before it can be marketed. The approval process is not expected to be difficult, because the pill does not enter or affect the body’s cells.